ホーム>>SR 142948 (hydrochloride)

SR 142948 (hydrochloride)

カタログ番号GC48100

多様な生物学的活性を持つ神経ペプチド

Products are for research use only. Not for human use. We do not sell to patients.

SR 142948 (hydrochloride) 化学構造

Cas No.: N/A

サイズ 価格 在庫数 個数
1 mg
$128.00
在庫あり
5 mg
$301.00
在庫あり
10 mg
$428.00
在庫あり

Tel:(909) 407-4943 Email: sales@glpbio.com

顧客レビュー

カスタマーレビューに基づきます。

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents

SR 142948 is an orally bioavailable non-peptide antagonist of neurotensin receptors (NTS; IC50s = 1.19, 0.32, and 3.96 nM for human recombinant NTS receptors expressed in CHO cells, HT-29 cells, and adult rat brain membranes, respectively).1 It inhibits inositol phosphate formation in HT-29 cells (IC50 = 3.9 nM) and intracellular calcium accumulation in CHO cells expressing human NTS receptors. SR 142948 (1 mg/kg, i.v.) inhibits the firing rate of rat ventral pallidum neurons with a longer duration of action than the NTS receptor antagonist SR 48692 .2 It also inhibits neurotensin-induced behavioral responses, including inhibition of neurotensin-induced turning behavior in mice when administered at doses ranging from 40 to 640 mg/kg and hypothermia and analgesia in rats and mice.1

1.Gully, D., Labeeuw, B., Boigegrain, R., et al.Biochemical and pharmacological activities of SR 142948A, a new potent neurotensin receptor antagonistJ. Pharmacol. Exp. Ther.280(2)802-812(1997) 2.Michaud, J.-C., Gueudet, C., and SoubriÉ, P.Effects of neurotensin receptor antagonists on the firing rate of rat ventral pallidum neuronsNeuroreport11(7)1437-1441(2000)

レビュー

Review for SR 142948 (hydrochloride)

Average Rating: 5 ★★★★★ (Based on Reviews and 28 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for SR 142948 (hydrochloride)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.